Abstract:OBJECTIVE:To investigate the relationship between serum VEGF (sVEGF) level and VEGF, COX-2 and MVD expression in breast cancer, and to discuss their role in angiogensis of breast cancer.METHODS:sVEGF level was detected by ELISA in 68 preoperative breast cancer, 35 benign breast disease and 20 healthy women. The expression of VEGF, COX-2 and MVD was detected by immunohistochemical method in tissues of breast cancer and breast benign diseases, and to analyze the relationship of sVEGF, VEGF, COX-2 and MVD.RESULTS:(1) sVEGF level in preoperative breast cancers was 306.51 pg/ml (interquartile range from 190.44 to 442.04 pg/ml), in benign diseases was 150.82 pg/ml (interquartile range from 82.36 to 212.34 pg/ml), and in healthy control was 105.93 pg/ml (interquartile range from 78.54 to 157.77 pg/ml). The sVEGF level of preoperative breast cancer group was significantly higher than that of breast benign disease group and healthy women (P = 0.001). (2) The VEGF expression positive rate in breast cancer (67.65%) was significantly higher than that in breast benign disease (44.12%) (P = 0.015). The COX-2 expression positive rate in breast cancer (42.86%) was significantly higher than that in breast benign disease (11.43%) (P = 0.002). (3) the COX-2 expression positive rate in sVEGF high level patients (56.00%) was significantly higher than that in sVEGF normal level patients (11.11%) (P = 0.024), and MVD in sVEGF high level patients (27.32 +/- 3.40) was also higher than that in sVEGF normal level patients (15.31 +/- 6.16) (P = 0.011). (4) The sVEGF level (322.09 +/- 79.31) of 68 breast cancer patients whose VEGF was positive in breast cancer tissues was significantly higher than that in VEGF negative group (222.47 +/- 73.53) (P = 0.017). (5) The COX-2 expression positive rate in VEGF positive expression group (65.21%) was significantly higher than that in VEGF negative expression group (18.18%) (P = 0.017). The MVD expression in COX-2 positive expression group (22.94 +/- 5.51) was significantly higher than that in COX-2 negative expression group (10.30 +/- 4.42) (P = 0.027).CONCLUSION:sVEGF level in breast cancer is significantly higher than that in breast benign disease and healthy women, and is correlated with the expression of COX-2 and MVD in breast cancer tissues.

Expressions of VEGF and survivin-2B mRNA in human breast cancer and tumor adjacent tissues and its clinical significance

A Study on the Expression of Survivin Gene in Human Gastric Cancer

The expression of survivin in human gastric carcinoma and precancerous lesions.

Clinicopathological Significance of Survivin Mrna Expression in HCC

Survivin and VEGF Expressions in Breast Cancer and their Relations

Expression of Survivin and MMP-2 in breast carcinoma and their correlation

Expression and clinical study of vascular endothelial growth factor and its receptors FLT-1, FLK-1/KDR in non-small cell lung cancer

Biological Significance Between Levels of VEGF-C in Serum and Tissue of Tumor and Lymph Vessel Density in Breast Cancer Patients

The Correlation Between Expression of Vascular Endothelial Growth Factor and Invasiveness and Metastasis of Gastric Carcinoma

Expression of vascular endothelial growth factor and Survivin in esophageal cancer and their relations with pathological manifestation

Correlation of the Expression of VEGF-C with CEA and Survivin and Their Correlation in Rectal Cancer

Expression and Significance of Angiopoietin-2 in Gastric Cancer.

Expression of Vascular Endothelial Growth Factor Receptor-2 in the Tissue of Basal Cell Carcinoma

Clinopathological Significance of Vascular Endothelial Growth Factor and Nm-23 Expression in Human Breast Cancer

Relationship Between Serum VEGF Level and VEGF, COX-2 and MVD Expression in Breast Cancer Tissues

Prognostic value of survivin expression in breast cancer

Expression of HER-2 and Its Relationship with Pathological Characteristics and Tumor Angiogenesis in Human Breast Cancer

Expression of Survivin and Its Correlation with VEGF in Non-small Cell Lung Cancer

Primary study of expression and correlationships of survivin protein and CD34 in endometrial carcinoma tissue

[Study of Mrna Expression of Vascular Endothelial Growth Factor-(A, C, D) Genes and Its Effect on Prognosis of Breast Cancer].

Increased Levels of Laptm4b, Vegf and Survivin Are Correlated with Tumor Progression and Poor Prognosis in Breast Cancer Patients